Can MR imaging biomarkers readily available in rural and underserved areas aid in the accurate clinical diagnosis of Alzheimer’s disease?
Background Hippocampal volume (HV) measured with brain magnetic resonance imaging (MRI), a NIA‐AA biomarker of Alzheimer’s disease (AD), could be widely available in rural and underserved areas in the United States. Amyloid positron imaging tomography (aPET) identifies the presence of amyloid AD pat...
Gespeichert in:
Veröffentlicht in: | Alzheimer's & dementia 2021-12, Vol.17 (S1), p.n/a |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!